Back

Obesity Society, The

  • Colitis, Ulcerative
  • Incretins
  • Inflammatory Bowel Diseases
  • Obesity

October 2026 Grand Rounds – Addressing Obesity in Patients with Inflammatory Bowel Disease

In this presentation, we will discuss the pathophysiology linking obesity and inflammatory bowel disease, including the impact of obesity on inflammation and the natural history of Crohn s disease and ulcerative colitis. We will also explore how dietary treatments and incretin therapies are being evaluated as adjunct therapies for the management of Crohn s disease and ulcerative colitis.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
Start Date
October 26, 2026
End Date
October 27, 2026
  • Live
  • Credit · Up to 1 credit
  • Paid · fee on provider site
  • When
    Oct 26, 2026